Oncosil Medical

Oncosil Medical Dividend

Dividend of Oncosil Medical (OSL.AX) as of Oct 28, 2026.

Dividend

0.00AUD

Last updated:

How much dividend does Oncosil Medical 2026 pay?

According to the latest status from October 2026, Oncosil Medical paid a total of 0.00 AUD per share in dividends within the last 12 months. With the current Oncosil Medical price of 0.71 AUD, this corresponds to a dividend yield of - %. A dividend is paid times per year.

Historical Oncosil Medical Dividends

Historical Oncosil Medical Dividends
PaydateDividend

The Oncosil Medical Dividend history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Date
Dividend
Jan 1, 2022
0.00 AUD
Jan 1, 2023
0.00 AUD
Jan 1, 2024
0.00 AUD
Jan 1, 2025
0.00 AUD
Jan 1, 2026
0.00 AUD
Jan 1, 2027 (e)
0.00 AUD
Jan 1, 2028 (e)
0.00 AUD
Jan 1, 2029 (e)
0.00 AUD
The Oncosil Medical Dividend history
YEARDividendYoY
est0.00AUD—
est0.00AUD—
est0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—
0.00AUD—

Is the Oncosil Medical Dividend Safe?

Oncosil Medical has been increasing the dividend for 0 years.

Analysts expect a Dividend Cut of -100.00% for the current fiscal year.

Dividend Details

Understanding Oncosil Medical's Dividend Distributions

Oncosil Medical’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Oncosil Medical's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Oncosil Medical's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Oncosil Medical’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Oncosil Medical Stock analysis

What does Oncosil Medical do? Oncosil Medical Ltd is an Australian company specializing in the development and distribution of innovative medical products for the treatment of cancer. The company was founded in 2005 and is based in Sydney. The business model of Oncosil Medical is based on research, development, and marketing of products specifically tailored to the needs of cancer patients. The company focuses on developing medical products that aim to improve the effectiveness of radiation therapy and chemotherapy. The core product of Oncosil Medical is the Oncosil implant. It is a small, implantable catheter containing tiny radioactive silicon particles. The implant is directly inserted into the tumor and releases controlled radiation to specifically destroy the tumor. The Oncosil implant is a promising and innovative new treatment option for many cancer patients. It is particularly suitable for patients with locally advanced pancreatic cancer, which is especially difficult to treat. Studies have shown that the Oncosil implant can significantly improve patients' survival rate. Oncosil Medical also provides other products, such as the Microsil transponder. The Microsil transponder is a small implant used in radiation therapy to make the irradiation of the tumor more effective. The transponder is directly inserted into the tumor, allowing medical professionals to precisely target the radiation to the tumor. In addition to developing and marketing innovative medical products, Oncosil Medical also has a research and development department. The company is constantly searching for new cancer treatment methods and works closely with scientists and researchers to develop new technologies. Oncosil Medical operates in several areas. In addition to developing and marketing medical products, the company also offers a training and education program for doctors and medical personnel. The program ensures that all users of Oncosil Medical's products have the necessary skills and knowledge to use the products safely and effectively. The company also has its own regulatory affairs department, which deals with the application for approvals for new products and procedures. This department works closely with authorities and regulatory agencies to ensure that all products from Oncosil Medical comply with applicable regulations and standards. Overall, Oncosil Medical is an innovative and emerging company specializing in the development and marketing of medical products for cancer treatment. With its highly skilled team of scientists, doctors, and qualified professionals, the company stays up to date with the latest research and technology to ensure that its products are always state-of-the-art and provide customers with the best possible treatment option. Oncosil Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Oncosil Medical stock

Oncosil Medical paid dividends every year for the past 0 years.

Oncosil Medical is assigned to the 'Health' sector.

The dividends of Oncosil Medical are distributed in AUD.

Dividend calendar 2026

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

All Key Metrics — Oncosil Medical